Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

Tharimmune (THAR) announced that the European Patent Office intends to grant the Company a patent covering biodegradable polymeric ...

The group was led by Casdin Capital, which surged 16 percent last month, according to an investor. This puts its share class that invests only in public securities up more than 40 percent for the year ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Acumen Pharmaceuticals, Inc. ( (ABOS) ) has released its Q3 earnings. Here is a breakdown of the information Acumen Pharmaceuticals, Inc.

The program taps into several OpenAI models and can be used across a wide range of therapeutic indications. Both Big Pharma ...

The patent covers the design, preparation and therapeutic application of nanoparticles formed ... including colonic targeting developed through the Company's partnership with Intract Pharma. While ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Since 1885, the UI’s College of Pharmacy has maintained several well-known programs while educating and training pharmacists ...

A Memphis-based company has branched out into an international market with a new licensing agreement. Hera Health Solutions, ...